Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422

Watchlist Manager
Sichuan Kelun Pharmaceutical Co Ltd Logo
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Watchlist
Price: 30.24 CNY -0.62%
Market Cap: 48.4B CNY
Have any thoughts about
Sichuan Kelun Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Sichuan Kelun Pharmaceutical Co Ltd

Wall Street analysts forecast Sichuan Kelun Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sichuan Kelun Pharmaceutical Co Ltd is 43.16 CNY with a low forecast of 39.39 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
39.39 CNY
30% Upside
Average
Price Target
43.16 CNY
43% Upside
Highest
Price Target
48.09 CNY
59% Upside
Sichuan Kelun Pharmaceutical Co Ltd Competitors:
Price Targets
600285
Henan Lingrui Pharmaceutical Co Ltd
38% Upside
BMY
Bristol-Myers Squibb Co
5% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
32% Downside
4521
Kaken Pharmaceutical Co Ltd
16% Upside
000513
Livzon Pharmaceutical Group Inc
8% Upside
OFSA3
Ouro Fino Saude Animal Participacoes SA
10% Upside

Revenue
Forecast

Revenue Estimate
Sichuan Kelun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 5%.

14%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sichuan Kelun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 10%.

17%
Past Growth
10%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Sichuan Kelun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 17%.

18%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sichuan Kelun Pharmaceutical Co Ltd's stock price target?
Price Target
43.16 CNY

According to Wall Street analysts, the average 1-year price target for Sichuan Kelun Pharmaceutical Co Ltd is 43.16 CNY with a low forecast of 39.39 CNY and a high forecast of 48.09 CNY.

What is Sichuan Kelun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 5%.

What is Sichuan Kelun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 10%.

What is Sichuan Kelun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 17%.

Back to Top